Skip to content

Health / AIA Financial Indonesia

AIA Health X

Health agency Full brief · 2026-05-15

AIA Health X is a Yearly Renewable Term (YRT) hospitalisation insurance from AIA Indonesia, built around a single unconventional proposition: premiums should rise when you claim heavily and stay controlled when you stay healthy.

★ The Insurer’s Play

analytical interpretation

Why this product exists

To capture recurring health-protection premiums in a fast-growing private-medical market — specifically, to use a loyalty mechanic to improve persistency and perceived value and sell a private "speed layer" sitting above public BPJS cover.

What the insurer wants the agent to do

Steer the agent to lead with the no-claim cashback / loyalty bonus, position it as a fast private top-up to BPJS, not a replacement, and attach and upsell supplementary riders.

Inferred from: no-claim cashback / loyalty mechanicBPJS positioningrider attachmentPOJK 36/2025 co-paymentaffluent / legacy segmentcompetitive positioning (§4)

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

✓ Fits when…

  • Age 25–45, health-conscious professional who exercises regularly
  • Young families with children under 18 — child insured attracts
  • Prospects who want one product to cover hospitalization in Asia
  • Digital-native customers comfortable with Vitality app gamification
  • Mass-market entry customers who want a recognisable brand with

~ Borderline — qualify carefully

  • Age 45–60 with history of claims or chronic conditions — X-Factor
  • Clients with existing employer group health — need to confirm
  • High-risk profession customers — exclusions include professional

✕ Not a fit when…

  • Customers with asthma, cardiovascular disease, thyroid disorders,
  • Clients who need treatment coverage in Singapore, Hong Kong, or
  • Clients who primarily need outpatient coverage (clinic visits
  • Clients with established heavy-claim history — X-Factor escalation

The trade-offs — when it wins, when it doesn’t

No product wins for everyone. Here’s when AIA Health X is the right call — and when a different product is.

PROSPECT: Healthy 28yo, no claims history, wants private room coverage at affordable price, familiar with fitness apps.

X-Factor rewards no-claim history with zero surcharge; Vitality integration aligns with fitness lifestyle; Rp 5B annual limit is strong at this price tier. Legacy Income counter: If prospect is open to Allianz, HS Care+ Plan D-F offers similar entry point with defined surgical tables and coverage to age 80; no behavioral pricing volatility.

PROSPECT: Parent wants health coverage for infant/child.

Zero X-Factor for under-18 regardless of claims; child premium is lower than adult; annual limit Rp 5B. Legacy Income counter: HS Care+ can also rider a child at lower cost; depends on base policy structure. Flexi Medical offers stronger outpatient if needed.

PROSPECT: Frequent traveller needing regional coverage.

Covers most of Asia including Malaysia, Thailand, China — good for regular Indonesia-region travel. Legacy Income counter: If client travels to Singapore or Japan regularly, AIA Health X explicitly fails. Allianz Preferred Medical or Flexi Medical with international scope is the stronger pitch.

PROSPECT: Client mentions "saya mau premi naik kalau saya klaim" as a concern (budget anxiety about premium escalation).

YRT base rate escalates with age annually; X-Factor can compound up to 200%; unlike term-guaranteed products, there is no rate-lock mechanism. Legacy Income pitch: HS Care+ premium is also age-scaled YRT but WITHOUT behavior-linked surcharges. More predictable escalation trajectory.

PROSPECT: Wants cancer treatment coverage integrated.

PROSPECT: Asking specifically about AIA Health X and whether they should take it.

Key facts

Coverage

  • Sum assured: not disclosed on page
  • Policy term: not disclosed on page
  • Pricing: not disclosed on page

Target Customer

Not specified on page.

Key Features

  • Asuransi Jiwa AIA Melangkah Bersama AIA PowerPro Life Optima Protection Plus Proteksi Jiwa Maksima (JIMI) AIA Nura Journ
  • AIA Melangkah Bersama
  • AIA PowerPro Life
  • Optima Protection Plus

⚠ Compliance red flags & mis-selling warnings

  1. POJK 36/2025 co-payment applicability — Essential X-Tra exposure. The OJK’s POJK 36/2025 introduced a mandatory co-payment framework for health insurance effective January 2026. Essential X (10% co-pay, max Rp 5M per treatment) appears to meet the co-pay requirement structurally. Essential X-Tra (zero co-pay) may face review under this regulation depending on OJK’s interpretation of standalone health product applicability. Agents should not represent Essential X-Tra as fully co-pay- exempt going forward without confirming AIA’s current OJK- compliant status for this plan. Check with AIA distributor network for current regulatory clearance status.

  2. X-Factor 200% escalation ceiling — must be disclosed at point of sale. The RIPLAY explicitly documents that the X-Factor plus accumulated X-Factor can reach a combined maximum of 200% of the standard premium. Agents who do not walk prospects through a worst-case illustration (heavy-claimer scenario over 5 years) are creating the conditions for a future dispute when premiums escalate significantly. At a minimum, show the brochure Scenario B (Michelle, Rp 250M claim, year 3 jump to Rp 13M+) to set expectations. OJK conduct-of-business requirements under POJK 69/2016 on fitness of insurance product illustrations require transparency in premium projection.

  3. Categorical exclusions vs. pre-existing waiting periods — distinguish clearly. AIA Health X’s exclusion list includes several conditions (asthma, COPD, cardiovascular disease, thyroid disorders, tonsil/adenoid/sinus, tuberculosis) that are excluded permanently, not merely deferred for 12 months as a pre-existing condition waiting period. Agents must not represent these as “waiting period conditions that will eventually be covered.” This distinction is a classic mis-selling vector in the Indonesian health insurance market.

  4. Singapore, Hong Kong, Japan exclusion — must be disclosed upfront for internationally mobile prospects. The geographic exclusion of three of Asia’s highest-cost medical markets is a material fact for any prospect who may seek treatment there. Failure to disclose this before premium payment is a policy- dispute risk and potentially an OJK complaint trigger.

  5. YRT premium non-guarantee — do not present as fixed premium. Health products on a Yearly Renewable Term basis carry non- guaranteed premiums. AIA can reprice the standard rate table at renewal. Combined with X-Factor adjustments, the total premium at year 10 cannot be guaranteed at time of sale. The brochure’s illustration is described as not binding and not a promise. Do not present any illustrated premium figure as the customer’s locked-in cost.

  6. AIA Vitality enrolment and membership fee — disclose Rp 50K/month or Rp 600K/year. The Vitality programme that enables X-Factor discounts carries a membership fee of Rp 600,000 per year (Rp 50,000/month). Agents should disclose this cost as part of the total cost of ownership when pitching the “your premium can go down with Vitality” story.

  7. Death benefit is nominal — not a life insurance substitute. AIA Health X carries a Rp 30 million death benefit. This is a technical inclusion for regulatory classification, not a meaningful life coverage amount. Agents must not position AIA Health X as providing meaningful death protection. The product is fundamentally a health cost reimbursement policy.


Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.

Expert · technical detail

Raw fields

Entity type
conventional
Channel
agency
Category
health
Benchmark carrier
no
Extraction quality
pdf-extracted
First cataloged
2026-04-24
Last updated
2026-04-24
Brief date
2026-05-15
Analyst confidence
High — both RIPLAY and brochure available; benefit tables

How Health products differ

Fully benchmarked · 93% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

Annual benefit limit qualitative
Rp 250M (entry tier — multiple insurers) Rp 20B (top-tier with auto-increase — Sun Healthcare Safir Plus)

Direct comparison limited by plan-tiering heterogeneity

Renewable to age qualitative

Observed: 80 · 99 · 100

Allianz AlliSya caps at age 80; Sun Healthcare Solution Syariah and Prudential PRUwell Medical Syariah both reach ~age 99-100; longest tail wins for younger entrants

Co-payment (POJK 36/2025) qualitative

POJK 36/2025 effective January 2026 — every health product across the category must apply a co-payment structure. Per-episode vs per-claim vs aggregate annual deductible structures vary; agents must explain the specific mechanism for the product being sold.

Underwriting qualitative
Geographic coverage qualitative

Most insurers offer Indonesia-only at entry tier; ASEAN regional coverage (Malaysia/Singapore) at mid-tier; global coverage at top-tier with reduced reimbursement percentage. Allianz AlliSya Flexi reportedly extends to US coverage at top tier.

Tabarru'/Ujrah split (Syariah) qualitative

Sun Healthcare Solution Syariah: 37-45% Ujrah depending on plan (high end on Opal/Safir). AIA Syariah typically 35-40%. Allianz Syariah varies.

Coverage caveat: Per-product detail extraction is at ~50% coverage across the 36 active health products. Cross-product comparisons in Section 5 of any health brief produced this run rely on qualitative observations and structured peer-product references (Allianz AlliSya line, Prudential PRU lines, and the four Sun Life Syariah briefs already produced — healthcare-solution-syariah, shifa-essential, shifa-signature, salam-anugerah-harapan). (sample: ~30 products)

Expert · full Strategic Brief

1. The 60-Second Pitch

AIA Health X is a Yearly Renewable Term (YRT) hospitalisation insurance from AIA Indonesia, built around a single unconventional proposition: premiums should rise when you claim heavily and stay controlled when you stay healthy. Its “X-Factor” mechanism links next-year premium adjustments directly to prior-year claim volume — adults who claim more than Rp 30 million see a 30% surcharge; those who claim below Rp 5 million (or are children) see no surcharge at all. Integrate with AIA Vitality and a Platinum wellness member with no claims can actually earn a 10% X-Factor discount. Two plan tiers — Essential X-Tra (no co-pay) and Essential X (10% co-pay, capped at Rp 5 million per treatment) — serve different willingness-to-share-risk profiles. Either way, the annual benefit limit is Rp 5 billion, with an additional Rp 12 billion lifetime Limit Booster that activates continuously while the policy is in force, creating an effective Rp 17 billion lifetime ceiling. For Legacy Income agents, AIA Health X is relevant as a competitive intelligence object: it directly contests the BPJS-to-private upgrade story that Allianz HS Care+ and Flexi Medical also occupy, and its X-Factor pitch is a genuine differentiator that prospects may raise when comparing options. Understanding where it leads and where it breaks is essential for handling those comparisons in the field.


2. Headline Numbers Decoded (official RIPLAY illustration cases)

The RIPLAY documents two illustration cases. Decoded below:


CASE 1: INDIVIDUAL POLICY

Insured/Policyholder

Pak Tony, age 35

Plan:Essential X-Tra (no co-pay)

Premium year 1:Rp 9,845,000 / year

Annual limit:Rp 5,000,000,000

Death benefit:Rp 30,000,000 Projected standard premium escalation (medical inflation, illustrative only):

Year 1:Rp 9,845,000

Year 2:Rp 11,089,000 (+13%)

Year 3:Rp 12,212,000 (+10%)

Year 4:Rp 13,056,000 (+7%)

Year 5:Rp 14,289,000 (+9%)

Note:figures above are BEFORE any X-Factor surcharge if claims occur. If Tony claims > Rp 30M, add +30% on top of the inflated standard rate.

CASE 2: CHILD INSURED

Insured

Andi, age 1 year

Policyholder:Pak Dedi (adult, parent)

Plan:Essential X (with co-pay)

Premium year 1:Rp 7,056,000 / year

Annual limit:Rp 5,000,000,000

Death benefit:Rp 30,000,000

X-Factor for child age <18: ZERO regardless of claim amount. Child premiums only follow age- based standard rate escalation. At year 3, Andi's actual claim of Rp 29M (within RIPLAY example) triggers NO X-Factor surcharge.

BROCHURE ILLUSTRATION: Michelle, 30F

Scenario A — No claims, Vitality Platinum

Year 1:Rp 7,956,000

Year 2:Rp 8,030,000 (Vitality 10% disc)

Year 3:Rp 8,035,000 (Vitality 20% cumul.)

Year 4:Rp 8,497,000 (Vitality 25% cumul.)

Note:Vitality discounts compound but cap out at levels shown per table. Scenario B — Rp 250M claim, Vitality Platinum:

Year 1:Rp 7,956,000

Year 2:Rp 8,030,000 (Platinum before claim)

Year 3:Rp 13,056,000 (+30% X-Factor, even with Platinum disc partially offsetting)

Year 4:Rp 14,727,000 (continued escalation) The X-Factor surcharge dominates; Vitality discount is modest mitigation.

CO-PAY MECHANICS: ESSENTIAL X PLAN

Hospital bill

Rp 100,000,000

Excluded items:Rp 100,000

Approved benefit:Rp 99,900,000

AIA X Co-pay:10% x Rp 99,900,000 = Rp 9,990,000 but capped at Rp 5,000,000

Customer pays:Rp 100,000 (exclusions) + Rp 5,000,000 (co-pay cap) = Rp 5,100,000 total out of pocket

LIMIT BOOSTER

Annual limit

Rp 5,000,000,000

Lifetime Limit Booster:Rp 12,000,000,000 (active while policy is in force, up to insured age 99)

Total lifetime ceiling:Rp 17,000,000,000

3. Ideal Customer Profile

Sweet Spot — Lead with AIA Health X

  • Age 25–45, health-conscious professional who exercises regularly and has low prior claim history — X-Factor works in their favour
  • Young families with children under 18 — child insured attracts zero X-Factor regardless of claims; ideal for paediatric coverage
  • Prospects who want one product to cover hospitalization in Asia broadly (not just Indonesia) — coverage across Asia except SG/HK/JP
  • Digital-native customers comfortable with Vitality app gamification and rewards programme as part of insurance value proposition
  • Mass-market entry customers who want a recognisable brand with Rp 5 billion annual limit at a lower base premium vs. premium products

Borderline Fit — Discuss but qualify carefully

  • Age 45–60 with history of claims or chronic conditions — X-Factor escalation + standard premium age-creep may make long-run cost unpredictable; needs honest projection of worst-case scenario
  • Clients with existing employer group health — need to confirm whether AIA Health X coordinates or pays as excess; co-pay may interplay with group coverage in complex ways
  • High-risk profession customers — exclusions include professional sports; underwriting may load or decline outright

Do Not Pitch

  • Customers with asthma, cardiovascular disease, thyroid disorders, TB, or tonsil/sinus conditions — these are categorical exclusions in the RIPLAY, not pre-existing waiting-period deferrals; these conditions are permanently excluded from benefit
  • Clients who need treatment coverage in Singapore, Hong Kong, or Japan specifically — AIA Health X explicitly excludes these three; route to a product with worldwide or SG/HK/JP-specific cover
  • Clients who primarily need outpatient coverage (clinic visits unrelated to hospitalisation) — AIA Health X covers outpatient only when linked to hospitalisation (pre/post admission); standalone outpatient is excluded
  • Clients with established heavy-claim history — X-Factor escalation to 200% of base premium is a documented ceiling risk; total premium cost may become unaffordable by year 5-7 for this segment

4. Decision Framework — When AIA Health X Beats the Alternatives


PROSPECT: Healthy 28yo, no claims history, wants private room coverage at affordable price, familiar with fitness apps.

X-Factor rewards no-claim history with zero surcharge; Vitality integration aligns with fitness lifestyle; Rp 5B annual limit is strong at this price tier. Legacy Income counter: If prospect is open to Allianz, HS Care+ Plan D-F offers similar entry point with defined surgical tables and coverage to age 80; no behavioral pricing volatility.

PROSPECT: Parent wants health coverage for infant/child.

Zero X-Factor for under-18 regardless of claims; child premium is lower than adult; annual limit Rp 5B. Legacy Income counter: HS Care+ can also rider a child at lower cost; depends on base policy structure. Flexi Medical offers stronger outpatient if needed.

PROSPECT: Frequent traveller needing regional coverage.

Covers most of Asia including Malaysia, Thailand, China — good for regular Indonesia-region travel. Legacy Income counter: If client travels to Singapore or Japan regularly, AIA Health X explicitly fails. Allianz Preferred Medical or Flexi Medical with international scope is the stronger pitch.

PROSPECT: Client mentions "saya mau premi naik kalau saya klaim" as a concern (budget anxiety about premium escalation).

YRT base rate escalates with age annually; X-Factor can compound up to 200%; unlike term-guaranteed products, there is no rate-lock mechanism. Legacy Income pitch: HS Care+ premium is also age-scaled YRT but WITHOUT behavior-linked surcharges. More predictable escalation trajectory.

PROSPECT: Wants cancer treatment coverage integrated.

PROSPECT: Asking specifically about AIA Health X and whether they should take it.

5. Product Benchmarking — AIA Health X vs. the Health Category


STRUCTURAL DIMENSIONS

PRODUCT STRUCTURE

Category norm:Health riders attached to base life policies (Allianz HS Care+, Prudential PruMedic etc.) OR standalone health (AXA Mandiri variants)

AIA Health X:Standalone health (no base policy required)

Read:AIA Health X is accessible without buying life insurance first. This lowers the barrier vs. rider-only products. Competitive advantage on recruitment simplicity.

COVERAGE HORIZON

Category norm:Renewable to age 75 (common), some to age 80

AIA Health X:Renewable to age 99 — among the longest

Read:Age-99 coverage horizon is a genuine differentiator. Most health products cap at 75 or 80; AIA extends risk into the highest-cost late-life window.

ANNUAL LIMIT

Category norm:Rp 500M–Rp 3B for standard plans; Rp 5B+ for premium tiers

AIA Health X:Rp 5,000,000,000 (BOTH plan tiers)

Read:Rp 5B on both plans — including the lower-premium Essential X with co-pay — is strong. Most products offer Rp 5B only on their most expensive tier.

LIFETIME LIMIT STRUCTURE

Category norm:Annual limit resets each year; no lifetime cap explicitly stated in most products

AIA Health X:Rp 12B Limit Booster (additional lifetime accumulator) → Rp 17B total effective ceiling

Read:The Limit Booster is a marketing-visible differentiator. Whether it represents real incremental value depends on claim frequency — heavy claimers may exhaust it; healthy members may not need it. Useful for long-lived rare high-cost events (organ transplant, prolonged ICU).

PLAN TIERS

Category norm:5–12 plan tiers is typical across health market

AIA Health X:2 tiers (Essential X-Tra, Essential X)

Read:Two-tier structure simplifies the choice but limits customisation. HS Care+'s 12 plans (Plans A-L) allow fine-grained room-rate matching; AIA Health X applies a single room standard (private, 1 bed, 1 bathroom).

GEOGRAPHIC COVERAGE

Category norm:Indonesia-only (most riders); some offer worldwide/international

AIA Health X:Asia-wide (excluding Singapore, HK, Japan)

Read:Regional-Asia coverage is mid-tier positioning. Better than Indonesia-only; less than worldwide. The SG/HK/JP exclusion is a notable gap for clients with cross-border exposure to those markets.

ECONOMIC DIMENSIONS

PREMIUM MECHANISM

Category norm:Fixed annual rate by age and plan at policy inception; rate increases at renewal based on age bracket and insurer repricing (non-guaranteed)

AIA Health X:YRT with dual-escalation: age-based standard rate + X-Factor claim-based surcharge (up to +30% per year, cumulative maximum 200% of base)

Read:X-Factor creates premium asymmetry. Healthy non-claimers benefit; heavy claimers face compounding cost escalation. Maximum effective premium = base rate x 200%, which is a material tail risk for high-claimers by policy year 5+.

CO-PAYMENT

Category norm:Some products have co-pay, some do not; POJK 36/2025 mandates co-payment framework effective January 2026 for health insurance

AIA Health X:Essential X-Tra: no co-pay (agent note: may face POJK 36/2025 compliance scrutiny — see

Section 8); Essential X: 10% co-pay capped at Rp 5M per treatment.

Read:The dual-plan structure pre-empts co-pay regulation by offering Essential X as a compliant co-pay option. Essential X-Tra no-co-pay status needs monitoring.

PREMIUM ILLUSTRATION (age 35, male)

Essential X-Tra:~Rp 9,845,000 / year (from RIPLAY)

Essential X:~Rp 7,956,000 / year (from brochure, 30F)

HS Care+ (Allianz, Plan F, age 40):~Rp 13,000,000 / year

Read:AIA Health X entry-level pricing appears competitive vs. HS Care+ at comparable plan levels. Direct comparison requires same-age same-plan grid, not available in this run. Treat as indicative only.

CANCER AND CRITICAL ILLNESS COVERAGE

CANCER TREATMENT

Category norm:Often requires CI rider or standalone add-on

AIA Health X:Included in base coverage — chemo, radio, targeted therapy, hormonal, immunotherapy, palliative care (max 180 days inpatient-linked)

Read:Cancer treatment inclusion in the base product is a genuine value-add and simplifies the pitch vs. products requiring separate CI rider for cancer treatment costs.

DIALYSIS

AIA Health X:Included (renal dialysis covered, no stated cap)

Category norm:Dialysis coverage varies; some products exclude or require separate chronic disease rider

Read:Dialysis inclusion alongside cancer is strong for clients with diabetes/renal family history.

POSITIONING SUMMARY

AIA Health X occupies the healthy-lifestyle-reward positioning

in the Indonesian health insurance market. Its structural

strengths — Rp 5B annual limit accessible on both plan tiers,

age-99 coverage horizon, Asia-wide geographic scope, and

cancer/dialysis inclusion in base — are genuinely competitive.

Its X-Factor mechanism is innovative and creates real premium

advantages for low-claimers, but the 200% escalation ceiling

and age-based standard rate compounding create meaningful

long-run premium uncertainty for high-claimers. For Legacy

Income agents, the product represents a competitor whose

primary positioning risk is the behav­iour-contingent pricing

narrative — healthy prospects may prefer AIA's "reward me for

staying well" framing over Allianz's predictable-premium model.

The counter-pitch is premium certainty and richer plan granularity

(HS Care+ 12 tiers vs. AIA's 2). Quantitative benchmarking

against the full 34-product health category is pending explicit

metric extraction run; this section reflects qualitative

comparison from available product documents.

6. Field Talking Points (EN + ID)

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Understanding the product — frame the comparison right

"AIA Health X is built on a premise: healthy people should pay

less. The X-Factor adjusts your premium based on what you claim.

No claim? No surcharge. Big claim? Next year costs more. They

pair this with AIA Vitality — a wellness rewards app — so active

members can offset some of that adjustment."

"AIA Health X itu punya konsep yang menarik: orang sehat bayar

lebih murah. Sistemnya namanya X-Factor — premi tahun depan

tergantung klaim yang kamu buat tahun ini. Tidak klaim? Tidak ada

tambahan biaya. Klaim besar? Premi naik. Mereka juga ada AIA

Vitality, jadi kalau kamu aktif olahraga dan sehat, bisa dapat

diskon premi."

The Rp 5 billion limit pitch

"Both plans — with or without co-pay — come with a Rp 5 billion

annual limit. That is one of the higher annual limits available

at this price tier. On top of that, there is a lifetime Limit

Booster of Rp 12 billion that accumulates continuously as long

as the policy is active. The practical intent is to protect

against very long-term, very expensive medical events."

"Kedua plan-nya, baik yang ada co-pay maupun yang tidak, punya

limit tahunan Rp 5 miliar. Itu salah satu yang paling tinggi di

kelasnya. Selain itu ada Limit Booster Rp 12 miliar yang aktif

terus selama polis jalan. Jadi kalau ada kejadian medis yang

sangat besar dan panjang, ada cadangan tambahan yang besar juga."

The X-Factor honest framing (for agents comparing)

"What X-Factor gives you is a reward if you stay healthy — your

premium either stays flat or drops slightly. What it takes away

is cost certainty if you claim heavily. A Rp 250 million claim

in one year could add 30% to your premium the following year,

on top of the regular annual rate increase that all health

products carry. Over several years of heavy claims, that

compounds significantly."

"X-Factor itu menarik kalau kamu sehat dan tidak banyak klaim

— premi terkontrol, bahkan bisa turun kalau aktif di Vitality.

Tapi kalau sampai rawat inap besar, misal Rp 250 juta dalam

satu tahun, premi tahun depannya naik 30% di atas kenaikan

standar tahunan yang memang sudah ada. Kalau ini terjadi

beberapa tahun berturut-turut, biayanya bisa sangat tinggi."

The co-pay clarification

"Essential X-Tra has no co-pay — AIA pays the approved benefit in

full. Essential X applies a 10% co-pay per treatment, capped at

Rp 5 million. The Essential X premium is lower. The practical

difference is: if you have an Rp 100 million claim on Essential X,

you pay Rp 5 million out of pocket. If you are on Essential X-Tra,

you pay nothing (beyond non-covered exclusions)."

"Plan Essential X-Tra tidak ada co-pay — AIA bayar penuh sesuai

manfaat yang disetujui. Essential X ada co-pay 10%, tapi

maksimal Rp 5 juta per perawatan. Preminya lebih murah. Bedanya

sederhana: kalau tagihan RS Rp 100 juta dan kamu di Essential X,

kamu hanya bayar Rp 5 juta dari kantong sendiri. Kalau di

Essential X-Tra, tidak bayar apa-apa di luar pengecualian polis."

7. Top 5 Customer Objections + Handling

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

1. “What happens to my premium if I get seriously ill?”

Customer

"Kalau saya sakit parah dan klaim besar, premi saya

jadi mahal banget tahun depannya?"

Don't say “Don’t worry, the Vitality discount will offset it.”

— Vitality discount is modest vs. a 30% X-Factor surcharge.

Don't say “Tenang aja, Vitality bisa offset kenaikannya.”

— Tidak akurat kalau klaim sangat besar.

Do say

"That is the right question to ask. If you claim more than

Rp 30 million in a policy year, AIA adds a 30% X-Factor

surcharge to your standard premium the next year. The standard

rate already increases with age every year — so the two

escalations run together. In a scenario with recurring large

claims, the total premium by year five or six could be

significantly higher than what you start with. This is the

trade-off for the lower entry premium and the Vitality reward

system. It is worth knowing before you commit."

Do say

"Itu pertanyaan yang penting. Kalau klaim kamu lebih dari

Rp 30 juta dalam satu tahun polis, AIA tambahkan 30% X-Factor

di atas premi standar tahun berikutnya. Premi standar itu

sendiri sudah naik setiap tahun sesuai usia. Jadi dua kenaikan

ini berjalan bersamaan. Dalam skenario klaim besar berulang,

total premi di tahun kelima atau keenam bisa jauh lebih tinggi

dari awal. Itu trade-off dari premi awal yang lebih rendah

dan sistem reward Vitality. Penting untuk tahu ini sebelum

memutuskan."

2. “Saya sering ke Singapura — apakah covered di sana?”

Customer

"Saya rutin ke Singapura untuk bisnis. Kalau saya sakit

di sana, AIA Health X cover tidak?"

Don't say “It covers all of Asia so you should be fine.”

— This is factually wrong; Singapore is explicitly excluded.

Don't say “Asia semua cover, jadi Singapura pasti masuk.”

— Salah; Singapura dikecualikan secara eksplisit di polis.

Do say

"AIA Health X covers most of Asia, but there are three specific

markets excluded from coverage: Singapore, Hong Kong, and Japan.

If you need treatment in any of those three countries, the policy

does not respond. Given that you travel to Singapore regularly

for business, this is a real coverage gap. You would want to

look at a product with worldwide or explicit Singapore coverage

for your situation."

Do say

"AIA Health X memang cover sebagian besar Asia, tapi ada tiga

negara yang dikecualikan: Singapura, Hong Kong, dan Jepang.

Kalau kamu butuh perawatan di salah satu dari tiga negara

itu, polis tidak membayar. Karena kamu rutin ke Singapura

untuk bisnis, ini jadi celah coverage yang nyata. Kamu perlu

cari produk yang ada worldwide coverage atau yang secara

spesifik cover Singapura."

3. “Saya punya asma — apa ini bisa di-cover?”

Customer

"Saya punya riwayat asma. Kalau saya klaim karena asma,

AIA Health X bayar tidak?"

Don't say “We can check at underwriting — it may get approved.”

— Asthma is a categorical exclusion, not a standard

pre-existing waiting period.

Don't say “Kita coba dulu ke underwriting, mungkin bisa disetujui.”

— Asma adalah pengecualian kategorikal, bukan pre-existing

waiting period biasa.

Do say

"Asthma is specifically named in the AIA Health X exclusions

list, alongside COPD — which means treatment for asthma and

related respiratory conditions is not covered regardless of

when it was diagnosed. It is not a pre-existing condition

situation where coverage kicks in after a waiting period; it

is a permanent categorical exclusion. You would need a health

product that does not categorically exclude asthma, or one

where the condition can be covered with a premium loading."

Do say

"Asma secara khusus disebutkan dalam daftar pengecualian

AIA Health X, bersama PPOK (penyakit paru obstruktif kronis).

Artinya perawatan yang berkaitan dengan asma tidak akan

dibayar, berapapun lama sudah didiagnosis. Ini bukan masa

tunggu pre-existing yang nanti selesai — ini pengecualian

permanen. Kamu perlu produk kesehatan yang tidak mengecualikan

asma secara kategorikal, atau produk yang bisa meng-cover

kondisi itu dengan loading premi."

4. “Kenapa harus beli ini kalau sudah ada BPJS?”

Customer

"Saya sudah bayar BPJS Kesehatan. Kenapa saya perlu bayar

lagi untuk AIA Health X?"

Don't say “BPJS is not enough — private insurance is much better.”

— Dismissing BPJS without specifics is not credible

and sounds like a sales script.

Don't say “BPJS tidak cukup — asuransi swasta jauh lebih baik.”

— Tanpa spesifik, ini terdengar seperti script penjualan.

Do say

"BPJS does its job well for what it is designed to do. The

limits of BPJS are worth understanding: you are admitted to

a BPJS class ward (typically class 2 or class 3 for most

members), the selection of hospitals is within the BPJS

network, and for high-cost events like extended ICU stays

or complex oncology treatment, the BPJS reimbursement may

not match the actual cost at a private hospital. AIA Health X

provides a private room, a Rp 5 billion annual limit, and

cashless access to AIA’s partner hospital network. The two

work differently — BPJS is your statutory safety net; this is

your private-hospital upgrade."

Do say

"BPJS itu bagus untuk fungsinya. Yang perlu dipahami adalah

batasannya: kamu masuk kelas bangsal BPJS, pilihan rumah

sakitnya dari jaringan BPJS, dan untuk kejadian mahal seperti

ICU panjang atau perawatan kanker di RS swasta, pembayaran

BPJS mungkin tidak menutupi biaya aktualnya. AIA Health X

kasih kamar pribadi, limit tahunan Rp 5 miliar, dan akses

cashless ke jaringan RS rekanan AIA. Keduanya fungsinya beda

— BPJS itu jaring pengaman wajib; ini upgrade ke layanan

swasta."

5. “Saya belum pernah sakit — kenapa premi mahal?”

Customer

"Saya orangnya sehat, jarang sakit. Kenapa premi per tahun

hampir Rp 10 juta?"

Don't say “It’s because everyone has risk, even healthy people.”

— Vague and does not address the value question.

Don't say “Karena semua orang punya risiko, meskipun sehat.”

— Samar dan tidak menjawab pertanyaan nilai.

Do say

"The premium you pay today is not because you are sick — it is

because the policy is there for when treatment costs become

serious. A single hospitalisation for appendix surgery in a

private hospital in Jakarta can run Rp 30 to 80 million. An

ICU stay of two weeks for dengue complications can reach Rp 150

million. The product is priced to cover those events, not

your average GP visit. The flip side of your good health is

exactly where AIA Health X’s X-Factor helps: as a healthy

non-claimer, your next year’s premium gets no surcharge, and

if you join AIA Vitality Platinum, you can earn a 10% discount

on top of that."

Do say

"Premi yang kamu bayar bukan karena kamu sakit sekarang —

tapi agar ada perlindungan ketika biaya perawatan jadi besar.

Operasi usus buntu di RS swasta Jakarta bisa Rp 30-80 juta.

Rawat inap ICU dua minggu karena demam berdarah komplikasi

bisa sampai Rp 150 juta. Produknya dihargai untuk cover

kejadian seperti itu, bukan kunjungan ke dokter biasa. Dan

justru karena kamu sehat, X-Factor itu menguntungkan kamu:

kalau tidak klaim, tidak ada surcharge tahun depan. Plus

kalau gabung AIA Vitality level Platinum, bisa dapat diskon

10% lagi."

8. Compliance Red Flags & Mis-Selling Warnings

  1. POJK 36/2025 co-payment applicability — Essential X-Tra exposure. The OJK’s POJK 36/2025 introduced a mandatory co-payment framework for health insurance effective January 2026. Essential X (10% co-pay, max Rp 5M per treatment) appears to meet the co-pay requirement structurally. Essential X-Tra (zero co-pay) may face review under this regulation depending on OJK’s interpretation of standalone health product applicability. Agents should not represent Essential X-Tra as fully co-pay- exempt going forward without confirming AIA’s current OJK- compliant status for this plan. Check with AIA distributor network for current regulatory clearance status.

  2. X-Factor 200% escalation ceiling — must be disclosed at point of sale. The RIPLAY explicitly documents that the X-Factor plus accumulated X-Factor can reach a combined maximum of 200% of the standard premium. Agents who do not walk prospects through a worst-case illustration (heavy-claimer scenario over 5 years) are creating the conditions for a future dispute when premiums escalate significantly. At a minimum, show the brochure Scenario B (Michelle, Rp 250M claim, year 3 jump to Rp 13M+) to set expectations. OJK conduct-of-business requirements under POJK 69/2016 on fitness of insurance product illustrations require transparency in premium projection.

  3. Categorical exclusions vs. pre-existing waiting periods — distinguish clearly. AIA Health X’s exclusion list includes several conditions (asthma, COPD, cardiovascular disease, thyroid disorders, tonsil/adenoid/sinus, tuberculosis) that are excluded permanently, not merely deferred for 12 months as a pre-existing condition waiting period. Agents must not represent these as “waiting period conditions that will eventually be covered.” This distinction is a classic mis-selling vector in the Indonesian health insurance market.

  4. Singapore, Hong Kong, Japan exclusion — must be disclosed upfront for internationally mobile prospects. The geographic exclusion of three of Asia’s highest-cost medical markets is a material fact for any prospect who may seek treatment there. Failure to disclose this before premium payment is a policy- dispute risk and potentially an OJK complaint trigger.

  5. YRT premium non-guarantee — do not present as fixed premium. Health products on a Yearly Renewable Term basis carry non- guaranteed premiums. AIA can reprice the standard rate table at renewal. Combined with X-Factor adjustments, the total premium at year 10 cannot be guaranteed at time of sale. The brochure’s illustration is described as not binding and not a promise. Do not present any illustrated premium figure as the customer’s locked-in cost.

  6. AIA Vitality enrolment and membership fee — disclose Rp 50K/month or Rp 600K/year. The Vitality programme that enables X-Factor discounts carries a membership fee of Rp 600,000 per year (Rp 50,000/month). Agents should disclose this cost as part of the total cost of ownership when pitching the “your premium can go down with Vitality” story.

  7. Death benefit is nominal — not a life insurance substitute. AIA Health X carries a Rp 30 million death benefit. This is a technical inclusion for regulatory classification, not a meaningful life coverage amount. Agents must not position AIA Health X as providing meaningful death protection. The product is fundamentally a health cost reimbursement policy.


9. Quick-Reference Spec Card


BASIC

PRODUCT AIA Health X

TYPE Health insurance (asuransi kesehatan)

Yearly Renewable Term (YRT)

INSURER PT AIA FINANCIAL (AIA Indonesia)

CHANNEL Agency / Direct Marketing

CURRENCY IDR (Rupiah) only

COVERAGE AREA Asia (excluding Singapore, Hong Kong, Japan)

REGULATORY OJK-licensed; document ref

RP167R02-1125

PRINT DATE November 2024

TERMS

ENTRY AGE

Insured:1 month to 70 years

Policyholder:Min 18 years

COVERAGE TO Age 99 (renewable annually)

POLICY TERM 1 year (auto-renewable)

PREMIUM PAYMENT Annual, semi-annual, quarterly, monthly

PLANS Essential X-Tra (no co-pay)

Essential X (10% co-pay, max Rp 5M/treatment)

GRACE PERIOD 45 calendar days from premium due date

FREE LOOK 14 calendar days from policy receipt

SURRENDER No surrender value (health insurance,

not savings)

BENEFITS (BOTH PLANS UNLESS NOTED)

ANNUAL LIMIT Rp 5,000,000,000

LIFETIME BOOSTER Rp 12,000,000,000 (active until age 99)

EFFECTIVE CEILING Rp 17,000,000,000

INPATIENT

Room:Private (1 bed, 1 bathroom), sesuai kuitansi

Floor:min Rp 1,500,000 / day or lower available private room rate, whichever higher

ICU:Sesuai kuitansi, max 365 days/yr incl. room; Vegetative state max 150 days

GP visits:Sesuai kuitansi

Specialist:Sesuai kuitansi

Surgery:Sesuai kuitansi

Prosthetics:Sesuai kuitansi

Ambulance:Sesuai kuitansi (local)

Hospital misc:Sesuai kuitansi

Companion:Included

OUTPATIENT (HOSPITALIZATION-LINKED ONLY)

Pre-admission:Sesuai kuitansi, max 30 days before admission

Post-discharge:Sesuai kuitansi, max 90 days after discharge

Physiotherapy:Sesuai kuitansi, max 90 visits/yr (within 30 days pre + inpatient + 90 days post)

Dialysis:Sesuai kuitansi

Emergency outpatient (accident):Sesuai kuitansi + 30-day follow-up

Dental (accident):Sesuai kuitansi (accident only)

Home nursing:Sesuai kuitansi, max 180 days/yr

Day surgery:Sesuai kuitansi Tropical disease (DF, typhoid, chikungunya, malaria): Sesuai kuitansi, max 10 visits/yr, max Rp 250,000/visit

CANCER TREATMENT

Chemo, radio, targeted, hormonal, immunotherapy:Sesuai kuitansi (within annual limit)

Palliative:Max 180 days/yr Post-cancer rehab + nutrition consult: Sesuai kuitansi, max 60 visits/yr, max Rp 400,000/visit; up to 5 years post- active treatment (cancer, stroke, MI)

DEATH BENEFIT Rp 30,000,000

PRICING MECHANISM

CO-PAY

Essential X-Tra:None

Essential X:10% of approved benefit, max Rp 5,000,000 per episode

X-FACTOR SURCHARGE (adults age 18+)

Claim ≤ Rp 5M or accident: 0% surcharge

Claim Rp 5M–30M: +15% next year

Claim > Rp 30M: +30% next year

Max combined X-Factor:200% of base standard rate

Children < 18: Zero X-Factor regardless

AIA VITALITY X-FACTOR DISCOUNT (annual membership Rp 600K)

Platinum + no claim:10% discount

Gold + no claim:3% discount

Silver + no claim:2% discount

Bronze or any claim:0%

PREMIUM EXAMPLES (from RIPLAY/brochure, indicative)

Age 1, Essential X:~Rp 7,056,000 / yr

Age 30F, Essential X:~Rp 7,956,000 / yr

Age 35M, Essential X-Tra:~Rp 9,845,000 / yr

WAITING PERIODS

General illness

30 calendar days

Special illness

12 months

Cancer

90 calendar days

HIV/AIDS

12 months

Accident

No waiting period

Death benefit

No waiting period

NOTABLE EXCLUSIONS

Categorical (permanent)

- Pre-existing conditions (Kondisi Yang Sudah Ada)

- Asthma / COPD

- Cardiovascular / vascular disease

- Thyroid disorders

- Tonsil, adenoid, sinus, septum conditions

- Tuberculosis

- Congenital disorders

- Cataract

- STDs / HIV (except specific workplace accident provision)

- Professional sports injuries

- Cosmetic / aesthetic treatments

- Robotic surgery

- Alternative / traditional medicine

- Nuclear / radiation events

- Maternity and pregnancy-related

- Routine checkups / screening / preventive care

- Dental (except accident-related)

Geographic

Singapore, Hong Kong, Japan

POLICY MECHANICS

CLAIMS (INPATIENT)

Cashless:AIA partner hospital network; leave AIA member card at admission

Reimbursement:Submit via WhatsApp 0811 1960 1000; TAT 8 business days

International treatment:Pre-authorization required 4 business days prior

RENEWAL Auto-renewal each year upon premium payment

CANCELLATION No refund of premiums paid if cancelled

mid-term; Free Look is 14 days

10. Action Items for Legacy Income (next 30 days)

  1. Build a one-page comparison handout contrasting AIA Health X X-Factor mechanism vs. Allianz HS Care+ premium-escalation structure. The handout should show a 10-year projection under both heavy-claim and no-claim scenarios. This addresses the most common field objection when prospects have seen AIA’s marketing.

  2. Verify OJK compliance status of AIA Health X Essential X-Tra (zero co-pay plan) under POJK 36/2025. If OJK has confirmed exemption or compliance, that removes a talking point; if there is a gap, it becomes a competitive intelligence advantage.

  3. Prepare a head-to-head briefing note for agents contrasting AIA Health X with Allianz Flexi Medical and HS Care+ on: annual limit, geographic coverage, co-pay structure, premium escalation risk, and cancer treatment scope. Format for WhatsApp delivery (short, mobile-readable, bilingual summary).

  4. Note the Singapore/Hong Kong/Japan exclusion as a standing counter-point for any prospect who mentions AIA Health X while regularly traveling to those markets. Prepare a clear, non- disparaging factual response: “AIA Health X covers most of Asia, but excludes SG/HK/JP. If those markets are relevant for you, here is what Allianz covers.”

  5. Watch the AIA Vitality programme for any changes to the X-Factor discount table or Vitality membership fee structure — these are AIA’s primary competitive differentiators and may change. Set a reminder to re-review this brief when any AIA health product update is detected by the morning scan task.


This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-04-24; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.